July 05, 2026
If you have been told you are prediabetic, have high fasting insulin, or simply cannot lose weight no matter what you do — insulin resistance is probably part of the picture. It is one of the most common and consequential metabolic conditions in urban India, and one of the least clearly explained to patients. This is the plain-language guide you should have been given.
Every time you eat carbohydrates — rice, roti, fruit, sugar — your blood glucose rises. Your pancreas responds by releasing insulin, a hormone whose job is to signal your cells to absorb that glucose and use it for energy. Think of insulin as a key and your cells as locked doors. The key opens the door, glucose enters the cell, and blood sugar returns to normal. This system works beautifully when it is functioning correctly.
Insulin resistance means your cells have stopped responding normally to the insulin key. The locks have become stiff. The pancreas compensates by producing more insulin — more keys — to force the same result. Blood glucose may stay controlled for years, but insulin levels are chronically elevated. And chronically high insulin has consequences that accumulate quietly and significantly.
Elevated insulin drives fat storage — particularly visceral fat that accumulates around the abdomen and organs. It promotes inflammation. It disrupts hormonal balance — in women, it stimulates the ovaries to produce excess testosterone, contributing to PCOS. It impairs sleep quality. It makes weight loss extremely difficult because high insulin keeps your body in storage mode rather than fat-burning mode. And eventually, as the pancreas exhausts itself trying to compensate, blood sugar begins to rise — prediabetes first, then type 2 diabetes. Read our metabolic health complete guide for the full clinical picture.
Indians have a genetic predisposition to store fat viscerally at lower BMIs compared to Western populations — a finding documented in the Journal of the Association of Physicians of India and reinforced by decades of clinical observation. This means an Indian at a "normal" BMI of 23 may have significantly more visceral fat and insulin resistance than a European at the same BMI. Add the urban Indian dietary pattern — high in refined carbohydrates (white rice, maida, sugar), low in fibre, high in vegetable oils — and the chronic stress and sleep deprivation of Pune and Mumbai's professional culture, and insulin resistance becomes almost expected rather than exceptional.
The most reliable initial test is fasting insulin alongside fasting glucose — allowing calculation of HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). A HOMA-IR above 1.5 suggests some insulin resistance; above 2.5 is considered significant. Many patients have never had fasting insulin tested, only fasting glucose — which is insufficient to identify insulin resistance in its early stages. Read our guide on metabolic blood markers that actually matter for the full panel worth checking.
The most evidence-backed interventions for insulin resistance are not exotic. Reducing refined carbohydrate intake — particularly added sugars and processed grains — meaningfully reduces the insulin demand after meals. Resistance training (lifting weights, bodyweight exercises) increases glucose uptake in muscle tissue independent of insulin, making muscles more sensitive to insulin's signal over time. Sleep restoration — which is genuinely difficult in Pune and Mumbai's working culture but genuinely important — reduces cortisol-driven insulin resistance. Where nutritional deficiencies (magnesium, vitamin D, B vitamins) are contributing to poor insulin sensitivity, addressing these through targeted supplementation or IV support plays a supporting role. The Trim & Tone Elixir and FatLoss Max programmes at ALIV are designed as clinical adjuncts to exactly this kind of structured metabolic programme.
HOMA-IR is calculated as: (fasting insulin in mIU/L × fasting glucose in mmol/L) ÷ 22.5. A result below 1.0 indicates excellent insulin sensitivity. Between 1.0 and 2.0 is normal. Between 2.0 and 2.9 suggests moderate insulin resistance. Above 3.0 indicates significant insulin resistance. These thresholds are guides, not absolute cutoffs — your clinical picture, symptoms, and family history inform interpretation alongside the number.
Yes — particularly in Indian populations where visceral fat accumulates at lower body weights than is typical in Western populations. Thin people with insulin resistance (sometimes called TOFI — thin outside, fat inside) are a significant clinical reality in India. Waist circumference and the waist-to-height ratio are more sensitive markers of metabolic risk in Indians than BMI alone. Read: waist circumference vs BMI in India.
The relationship is bidirectional. Insulin resistance drives excess androgen production in the ovaries — contributing significantly to PCOS. PCOS in turn perpetuates insulin resistance through hormonal and metabolic mechanisms. Up to 70% of women with PCOS have insulin resistance regardless of body weight. Addressing insulin resistance is therefore central to managing PCOS, not peripheral to it. Read our dedicated guide: PCOS and insulin resistance.
With consistent dietary change, regular resistance training, adequate sleep, and management of chronic stress — measurable improvements in HOMA-IR are typically seen within eight to twelve weeks. More significant restoration of insulin sensitivity, particularly in patients with moderate to significant resistance, takes six to twelve months of sustained effort. The body responds, but it responds at the rate of biology — not at the rate of motivation.
Directly, no — IV therapy is not a primary treatment for insulin resistance. Indirectly, addressing the specific nutritional deficiencies that worsen insulin sensitivity — magnesium, B vitamins, vitamin D — through IV or oral supplementation supports the metabolic environment in which insulin resistance improves. IV therapy at ALIV in this context is a clinical adjunct to foundational lifestyle intervention, not a replacement for it.